Filing Manager
BIGGER CAPITAL FUND L P
Reporting Manager
Bigger Michael
Symbol
RSLS
Shares outstanding
3,305,785 shares
Disclosed Ownership
320,000 shares
Ownership
9.7%
Form type
SCHEDULE 13G
Filing time
21 Feb 2025, 17:28:24 UTC
Date of event
18 Feb 2025

Quoteable Key Fact

"BIGGER CAPITAL FUND L P disclosed 9.7% ownership in ReShape Lifesciences Inc. Common Stock, $0.001 par value (RSLS) on 18 Feb 2025."

Quick Takeaways

  • BIGGER CAPITAL FUND L P filed SCHEDULE 13G for ReShape Lifesciences Inc. Common Stock, $0.001 par value (RSLS).
  • Disclosed ownership: 9.7%.
  • Date of event: 18 Feb 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 21 Feb 2025, 17:28.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIGGER CAPITAL FUND L P 4.8% 160,000 0 160,000 /s/ Michael Bigger Michael Bigger, Managing Member of Bigger Capital Fund GP, LLC, its general partner
Bigger Capital Fund GP, LLC 4.8% 160,000 0 160,000 /s/ Michael Bigger Michael Bigger, Managing Member
District 2 Capital Fund LP 4.8% 160,000 0 160,000 /s/ Michael Bigger Michael Bigger, Managing Member of District 2 GP LLC, its general partner
District 2 Capital LP 4.8% 160,000 0 160,000 /s/ Michael Bigger Michael Bigger, Managing Member
District 2 GP LLC 4.8% 160,000 0 160,000 /s/ Michael Bigger Michael Bigger, Managing Member
District 2 Holdings LLC 4.8% 160,000 0 160,000 /s/ Michael Bigger Michael Bigger, Managing Member
Bigger Michael 9.7% 320,000 0 320,000 /s/ Michael Bigger Michael Bigger
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .